EMED Technologies, a global leader in drug delivery and innovative infusion therapy devices, announced the members of its Scientific Advisory Board (SAB). Established in 1991, EMED Technologies is a ...

Though Yaccarino does not have experience in health tech, eMed said in a press release that they sought her out for her ...

The eMed Population Health digital health platform announced Tuesday that former X Chief Executive Officer Linda Yaccarino ...

Linda Yaccarino is taking the top job at eMed Population Health, a telehealth startup focused on GLP-1 weight loss drugs, ...

Linda Yaccarino, less than a month after stepping down as CEO of Elon Musk’s X, has found her next gig. Yaccarino has been ...

Miami-based eMed, which focuses on health management for the GLP-1 and GIP population, said Yaccarino’s experience will be ...

Linda Yaccarino, the former X CEO who left the social media company in the wake of yet another Elon Musk controversy, has ...

Just a month after her exit from Musk's X, the tech executive will lead the digital platform for GLP-1 health management ...

Digital health platform eMed Population Health said on Tuesday it has appointed Linda Yaccarino, the former CEO of social ...

The post, at the company that focuses on care for GLP-1 users, comes after Yaccarino left Elon Musk's X in July.